References
- Kubavat HA , ShurJ, RuecroftG, HipkissD, PriceR. Investigation into the influence of primary crystallization conditions on the mechanical properties and secondary processing behaviour of fluticasone propionate for carrier based dry-powder inhaler formulations. Pharm. Res.29(4), 994–1006 (2012).
- Saleem I , SmythH, TelkoM. Prediction of dry-powder inhaler formulation performance from surface energetics and blending dynamics. Drug Dev. Ind. Pharm.34(9), 1002–1010 (2008).
- Hickey AJ , MansourHM, TelkoMJet al. Physical characterization of component particles included in dry-powder inhalers. I Strategy review and static characteristics. J. Pharm. Sci. 96(5), 1282–1301 (2007).
- Kubavat HA , ShurJ, RuecroftG, HipkissD, PriceR. Influence of primary crystallisation conditions on the mechanical and interfacial properties of micronised budesonide for dry powder inhalation. Int. J. Pharm.430(1–2), 26–33 (2012).
- Colombo I , GrassiG, GrassiM. Drug mechanochemical activation. J. Pharm. Sci.98, 3961–3986.
- Huttenrauch R , FrickeS, ZielkeP. Mechanical activation of pharmaceutical systems. Pharm. Res.2(6), 302–306.
- Willart JF , DescampsM. Solid state amorphization of pharmaceuticals. Mol. Pharm.5, 905–920 (2008).
- Tanaka K , KitamuraS, KitagawaT. Effect of structural relaxation on the physical and aerosol properties of amorphous form of FK888 (NK1 antagonist). Chem. Pharm. Bull.53(5), 498–502 (2005).
- Brodka-Pfeiffer K , HäuslerH, GrassP, LangguthP. Conditioning following powder micronization: influence on particle growth of salbutamol sulfate. Drug Dev. Ind. Pharm.29(10), 1077–1084 (2003).
- Jones MD , YoungPM, TrainiD, ShurJ, EdgeS, PriceR. The use of atomic force microscopy to study the conditioning of micronised budesonide. Int. J. Pharm.357(1–2), 314–317 (2008).
- Palakodaty S , YorkP, PritchardJ. Supercritical fluid processing of materials from aqueous solutions: the application of SEDS to lactose as a model substance. Pharm. Res.15(12), 1835–1843 (1998).
- Chiou H , LiL, HuT, Chan H-K, Chen J-F, Yun J. Production of salbutamol sulfate for inhalation by high-gravity controlled antisolvent precipitation. Int. J. Pharm.331(1), 93–98 (2007).
- Kaerger JS , PriceR. Processing of spherical crystalline particles via a novel solution atomization and crystallization by sonication (SAXS) technique. Pharm. Res.21(2), 372–381 (2004).
- Pitchayajittipong C , ShurJ, PriceR. Engineering of crystalline combination inhalation particles of a long-acting beta2-agonist and a corticosteroid. Pharm. Res.26(12), 2657–2666 (2009).
- Young PM , PriceR. The influence of humidity on the aerosolisation of micronised and SEDS produced salbutamol sulphate. Eur. J. Pharm. Sci.22(4), 235–240 (2004).
- Gaisford S , DennisonM, TawfikM, JonesMD. Following mechanical activation of salbutamol sulphate during ball-milling with isothermal calorimetry. Int. J. Pharm.393(1–2), 74–78 (2010).
- El-Sabawi D , PriceR, EdgeS, YoungPM. Novel temperature controlled surface dissolution of excipient particles for carrier based dry-powder inhaler formulations. Drug Dev. Ind. Pharm.32(2), 243–251 (2006).
- Hooton JC , JonesMD, HarrisH, ShurJ, PriceR. The influence of crystal habit on the prediction of dry powder inhalation formulation performance using the cohesive-adhesive force balance approach. Drug Dev. Ind. Pharm.34(9), 974–983 (2008).
- Begat P , MortonDAV, StaniforthJN, PriceR. The cohesive-adhesive balances in dry-powder inhaler formulations. I: Direct quantification by atomic force microscopy. Pharm. Res.21(9), 1591–1597 (2004).
- Young PM , TobynMJ, PriceR, ButtrumM, DeyF. The use of colloid probe microscopy to predict aerosolization performance in dry-powder inhalers: AFM and in vitro correlation. J. Pharm. Sci.95(8), 1800–1809 (2006).
- Gaisford S . Isothermal microcalorimetry for quantifying amorphous content in processed pharmaceuticals. Adv. Drug Deliv. Rev.64, 431–439 (2012).
- Begat P , YoungPM, EdgeS, KaergerJS, PriceR. The effect of mechanical processing on surface stability of pharmaceutical powders: visualization by atomic force microscopy. J. Pharm. Sci.92(3), 611–620 (2003).
- Price R , YoungPM. On the physical transformations of processed pharmaceutical solids. Micron36, 519–524 (2005).
- Jones MD , HarrisH, HootonJCet al. An investigation into the relationship between carrier-based dry powder inhalation performance and formulation cohesive-adhesive force balances. Eur. J. Pharm. Biopharm. 69(2), 496–507 (2008).
Patent
- Astra A: US5637620 A (1995).